Literature DB >> 18094301

Side-hole catheter placement for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer: long-term treatment and survival benefit.

Hiroshi Seki1, Toshirou Ozaki, Makoto Shiina.   

Abstract

OBJECTIVE: The objective of this study was to evaluate retrospectively correlations between catheter placement methods and treatment outcomes of patients treated with hepatic arterial infusion chemotherapy for unresectable liver metastases from colorectal cancer.
MATERIALS AND METHODS: This study involved 135 patients with liver metastases from colorectal cancer who underwent intrahepatic chemotherapy using catheter-port systems. Complications, treatment discontinuation, hepatic progression, and survival of patients treated with each method were evaluated retrospectively using the Kaplan-Meier method. Conventional 5-French end-hole catheter placement (n = 10) was compared with three side-hole catheter placement methods: 5-French side-hole catheter placement with a fixed catheter tip (original fixed catheter tip method, n = 77); long tapered side-hole catheter placement using a fixed catheter tip method (modified fixed catheter tip method, n = 24); and long tapered side-hole catheter inserted distally in the hepatic artery (long tapered catheter placement method, n = 24).
RESULTS: The following treatment outcomes were significantly better for patients treated using the original or modified fixed catheter tip or long tapered catheter placement method than for those treated using the conventional method, respectively: hepatic arterial patency (1 year: 76.3%, 95.0%, and 94.4% vs 38.9%; p = 0.0014, 0.0007, and 0.0006), catheter stability (1 year: 96.7%, 95.5%, and 95.2% vs 42.9%; p < 0.0001, p = 0.0003, and p = 0.0009), time to treatment discontinuation (medians: 11.7, 14.4, and 12.4 vs 3.2 months; p < 0.0001, 0.0002, and 0.0019), time to hepatic progression (medians: 14.7, 15.7, and 15.8 vs 5.5 months; p = 0.0049, 0.0141, and 0.0004), and overall survival (medians: 21.1, 22.5, and 23.1 vs 13.1 months; p = 0.0146, 0.0036, and 0.0017).
CONCLUSION: Compared with the conventional method, side-hole catheter placement methods allowed long-term intrahepatic chemotherapy and resulted in improved survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18094301     DOI: 10.2214/ajr.07.2038

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  A simplified technique of percutaneous hepatic artery port-catheter insertion for the treatment of advanced hepatocellular carcinoma with portal vein invasion.

Authors:  Sun Young Choi; Ah Hyun Kim; Kyung Ah Kim; Jong Yun Won; Do Yun Lee; Kwang-Hun Lee
Journal:  Korean J Radiol       Date:  2010-10-29       Impact factor: 3.500

2.  Complications in hepatic arterial infusion chemotherapy: retrospective comparison of catheter tip placement in the right/left hepatic artery vs. the gastroduodenal artery.

Authors:  Rinpei Imamine; Toshiya Shibata; Ken Shinozuka; Kaori Togashi
Journal:  Surg Today       Date:  2017-02-10       Impact factor: 2.549

3.  Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement.

Authors:  P J Karanicolas; P Metrakos; K Chan; T Asmis; E Chen; T P Kingham; N Kemeny; G Porter; R C Fields; J Pingpank; E Dixon; A Wei; S Cleary; G Zogopoulos; C Dey; M D'Angelica; Y Fong; S Dowden; Y J Ko
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

4.  Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.

Authors:  T Susanna Meijer; Lioe-Fee de Geus-Oei; Christian H Martini; Fred G J Tijl; M Elske Sitsen; Arian R van Erkel; Rutger W van der Meer; Ellen Kapiteijn; Alexander L Vahrmeijer; Mark C Burgmans
Journal:  Diagn Interv Radiol       Date:  2019-11       Impact factor: 2.630

5.  Percutaneous Implantation of a Microcatheter-Port System for Hepatic Arterial Infusion Chemotherapy of Unresectable Liver Tumors: Technical Feasibility, Functionality, and Complications.

Authors:  Olivier Chevallier; Ségolène Mvouama; Julie Pellegrinelli; Kévin Guillen; Sylvain Manfredi; François Ghiringhelli; Nicolas Falvo; Marco Midulla; Romaric Loffroy
Journal:  Diagnostics (Basel)       Date:  2021-02-26

6.  Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients.

Authors:  Stefano Bacchetti; Enricomaria Pasqual; Elena Crozzolo; Alessandra Pellarin; Pier Paolo Cagol
Journal:  Med Devices (Auckl)       Date:  2009-03-16

7.  Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy.

Authors:  Yasutaka Baba; Jun-Ichiro Sonoda; Sadao Hayashi; Nanako Tosuji; Shunro Sonoda; Kanro Makisumi; Masayuki Nakajo
Journal:  Exp Ther Med       Date:  2012-06-07       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.